|
ISIN No
|
INE594H01019
|
BSE Code / NSE Code
|
539871 / THYROCARE
|
Book Value (Rs.)
|
39.97
|
Face Value
|
10.00
|
|
Bookclosure
|
23/06/2026
|
52Week High
|
662
|
EPS
|
10.24
|
P/E
|
53.05
|
|
Market Cap.
|
8648.25 Cr.
|
52Week Low
|
343
|
P/BV / Div Yield (%)
|
13.60 / 2.58
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
The company history sections lists out major chronological events that happened to the company.
| The Company was incorporated as Thyrocare Technologies Limited on January 28, 2000 at Mumbai as a public limited company under the Companies Act, 1956. the Company was issued a certificate of commencement of business from the RoC on March 7, 2000.
Major events and milestones of the Company :
2000
-The Company was incorporated in the name and style of "Thyrocare Technologies Limited' and received a certificate for commencement of operations.
2001
-The Company received ISO 9001 certification.
-The Company commenced commercial operations under the brand name 'Thyrocare'
pursuant to the acquisition of business of TDPL and TBPL (which were incorporated in 1996).
2005
-The Company received NABL accreditation.
2006
-The Company issued certain fully convertible debentures aggregating to 250 million to BCCL.
2007
-The Company receives accreditation from the College of American Pathologists (CAP).
2010
-The Company issued certain compulsorily convertible debentures aggregating to 250 million to Agalia. Agalia also acquired certain Equity Shares aggregating to 1,250 million from the Promoters and certain other persons.
-The Company launched wellness packages under the brand name "Aarogyam".
2011
-The Company migrated to "total laboratory automation system" installed by Siemens for efficient handling of increasing volumes.
2012
-NVP acquired certain Equity Shares aggregating to 1,200 million from certain entities.
2013
-EIF acquired certain Equity Shares from Agalia.
-The Subsidiary commenced operations at the PET-CT centres at Navi Mumbai and
conducted over 1,000 scans in the first year of operation.
2014
-The Company had installed, India's first and the world's longest track automation system for seamless sample movements from Siemens Limited.
-The Company commissioned the operations in medical cyclotron facility in Navi Mumbai.
-The Subsidiary commenced operations at the PET-CT centres in New Delhi and Hyderabad and the PET-CT centres at New Delhi conducted over 1,000 scans in the first year of operations.
2015
-The Company opened RPLs in Delhi, Coimbatore, Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily.
-The Company acquired the equipment for testing of water samples and commenced operating the equipment under the brand name "WHATERS". These tests, at present include physical and chemical testing, elements testing, microbiology testing, pesticide testing and volatile organic compounds testing.
-The Subsidiary has completed over 10,000 scans at the PET-CT centres in New Delhi, over 10,000 scans at the PET-CT centres in Navi Mumbai from the date of inception and over 1,000 scans at the PET-CT centres in Hyderabad since inception.
2016
-Thyrocare Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities.
2024 -Thyrocare Technologies Completed acquisition of Think Health Diagnostic Private Limited.
2025 -The Company has issued Bonus Shares in the Ratio of 2:1.
|